A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts ; volume:10 ; number:1 ; day:3 ; month:7 ; year:2020 ; pages:1-13 ; date:12.2020
EJNMMI Research ; 10, Heft 1 (3.7.2020), 1-13, 12.2020
- Creator
-
Paquette, Michel
Phoenix, Serge
Lawson, Christine
Guérin, Brigitte
Lecomte, Roger
Tai, Lee-Hwa
Turcotte, Éric E.
Leyton, Jeffrey V.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-020-00656-8
- URN
-
urn:nbn:de:101:1-2020083119220545542026
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Paquette, Michel
- Phoenix, Serge
- Lawson, Christine
- Guérin, Brigitte
- Lecomte, Roger
- Tai, Lee-Hwa
- Turcotte, Éric E.
- Leyton, Jeffrey V.
- SpringerLink (Online service)
Other Objects (12)
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived xenografts: a relevant preclinical model for drug development
Dual HER2 blockade: preclinical and clinical data
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
Erratum to: Dual HER2 blockade: preclinical and clinical data
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Preclinical research progress in HER2-targeted small-molecule probes for breast cancer
Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine
Tracer
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived xenografts: a relevant preclinical model for drug development
Dual HER2 blockade: preclinical and clinical data
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
Erratum to: Dual HER2 blockade: preclinical and clinical data
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Preclinical research progress in HER2-targeted small-molecule probes for breast cancer
Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine
Tracer
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived xenografts: a relevant preclinical model for drug development
Dual HER2 blockade: preclinical and clinical data
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
Erratum to: Dual HER2 blockade: preclinical and clinical data
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Preclinical research progress in HER2-targeted small-molecule probes for breast cancer
Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine